Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.

van den Ende RPJ, Peters FP, Harderwijk E, Rütten H, Bouwmans L, Berbee M, Canters RAM, Stoian G, Compagner K, Rozema T, de Smet M, Intven MPW, Tijssen RHN, Theuws J, van Haaren P, van Triest B, Eekhout D, Marijnen CAM, van der Heide UA, Kerkhof EM.

Radiat Oncol. 2020 Feb 18;15(1):41. doi: 10.1186/s13014-020-01487-6.

2.

Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.

Kok END, Havenga K, Tanis PJ, de Wilt JHW, Hagendoorn J, Peters FP, Buijsen J, Rutten HJT, Kuhlmann KFD; Dutch Stage IV Rectal Cancer Group.

Br J Surg. 2020 Feb 3. doi: 10.1002/bjs.11418. [Epub ahead of print]

PMID:
32017049
3.

When and how should surgery be performed in senior colorectal cancer patients?

Ketelaers SHJ, Fahim M, Rutten HJT, Smits AB, Orsini RG.

Eur J Surg Oncol. 2020 Mar;46(3):326-332. doi: 10.1016/j.ejso.2020.01.007. Epub 2020 Jan 9.

PMID:
31955993
4.

Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only.

Haanappel A, Kroon HM, Schaap DP, Bedrikovetski S, Dudi-Venkata NN, Lee HX, Thomas ML, Liu J, van der Valk MJM, Rutten HJT, Beets GL, Kusters M, Sammour T.

Front Oncol. 2019 Dec 3;9:1355. doi: 10.3389/fonc.2019.01355. eCollection 2019.

5.

Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study.

Vermeulen BD, Jeene PM, Sijben J, Krol R, Rütten H, Bogers JA, Braam PM, Siersema PD.

Pract Radiat Oncol. 2019 Oct 24. pii: S1879-8500(19)30316-9. doi: 10.1016/j.prro.2019.10.010. [Epub ahead of print]

PMID:
31669401
6.

The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper.

Valentini V, Marijnen C, Beets G, Bujko K, De Bari B, Cervantes A, Chiloiro G, Coco C, Gambacorta MA, Glynne-Jones R, Haustermans K, Meldolesi E, Peters F, Rödel C, Rutten H, van de Velde C, Aristei C.

Radiother Oncol. 2020 Jan;142:6-16. doi: 10.1016/j.radonc.2019.07.001. Epub 2019 Aug 17.

PMID:
31431374
7.

A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.

Beek MA, Gobardhan PD, Klompenhouwer EG, Menke-Pluijmers MB, Steenvoorde P, Merkus JW, Rutten HJ, Voogd AC, Luiten EJ.

Eur J Surg Oncol. 2020 Jan;46(1):59-64. doi: 10.1016/j.ejso.2019.08.003. Epub 2019 Aug 5.

PMID:
31402072
8.

Functional bowel complaints and quality of life after surgery for colon cancer: prevalence and predictive factors.

van Heinsbergen M, den Haan N, Maaskant-Braat AJ, Melenhorst J, Belgers EH, Leijtens JW, Bloemen JG, Rutten HJ, Bouvy ND, Janssen-Heijnen ML, Konsten JL.

Colorectal Dis. 2020 Feb;22(2):136-145. doi: 10.1111/codi.14818. Epub 2019 Sep 3.

PMID:
31397962
9.

The role of the longitudinal muscle in the anal sphincter complex: Implications for the Intersphincteric Plane in Low Rectal Cancer Surgery?

Kraima AC, West NP, Roberts N, Magee DR, Smit NN, van de Velde CJH, DeRuiter MC, Rutten HJ, Quirke P.

Clin Anat. 2019 Aug 5. doi: 10.1002/ca.23444. [Epub ahead of print]

PMID:
31385374
10.

Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.

Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Rutten HJT, Tuynman JB, Kusters M; Lateral Node Study Consortium.

JAMA Surg. 2019 Jul 3:e192172. doi: 10.1001/jamasurg.2019.2172. [Epub ahead of print]

PMID:
31268504
11.

Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years.

Ketelaers SHJ, Orsini RG, Burger JWA, Nieuwenhuijzen GAP, Rutten HJT.

Eur J Surg Oncol. 2019 Nov;45(11):2052-2058. doi: 10.1016/j.ejso.2019.06.017. Epub 2019 Jun 13.

PMID:
31255442
12.

Inter-hospital variation in resection rates of colon cancer in the Netherlands: A nationwide study.

Giesen LJX, van Erning FN, Vissers PAJ, Maas HAAM, Rutten HJT, Lemmens VEPP, Dekker JWT.

Eur J Surg Oncol. 2019 Oct;45(10):1882-1886. doi: 10.1016/j.ejso.2019.06.012. Epub 2019 Jun 8.

PMID:
31202571
13.

The gap in postoperative outcome between older and younger patients with stage I-III colorectal cancer has been bridged; results from the Netherlands cancer registry.

Brouwer NPM, Heil TC, Olde Rikkert MGM, Lemmens VEPP, Rutten HJT, de Wilt JHW, van Erning FN.

Eur J Cancer. 2019 Jul;116:1-9. doi: 10.1016/j.ejca.2019.04.036. Epub 2019 Jun 1.

PMID:
31163335
14.

Colonoscopy Surveillance After Colorectal Cancer: the Optimal Interval for Follow-Up.

Ramphal W, Boeding JRE, Schreinemakers JMJ, Gobardhan PD, Rutten HJT, Crolla RMPH.

J Gastrointest Cancer. 2019 Jun 3. doi: 10.1007/s12029-019-00254-5. [Epub ahead of print]

PMID:
31155695
15.

Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.

Claassen YHM, Bastiaannet E, van Eycken E, Van Damme N, Martling A, Johansson R, Iversen LH, Ingeholm P, Lemmens VEPP, Liefers GJ, Holman FA, Dekker JWT, Portielje JEA, Rutten HJ, van de Velde CJH.

Eur J Surg Oncol. 2019 Aug;45(8):1396-1402. doi: 10.1016/j.ejso.2019.03.041. Epub 2019 Apr 9.

PMID:
31003722
16.

Definition of the Rectum: An International, Expert-based Delphi Consensus.

DʼSouza N, de Neree Tot Babberich MPM, d'Hoore A, Tiret E, Xynos E, Beets-Tan RGH, Nagtegaal ID, Blomqvist L, Holm T, Glimelius B, Lacy A, Cervantes A, Glynne-Jones R, West NP, Perez RO, Quadros C, Lee KY, Madiba TE, Wexner SD, Garcia-Aguilar J, Sahani D, Moran B, Tekkis P, Rutten HJ, Tanis PJ, Wiggers T, Brown G.

Ann Surg. 2019 Dec;270(6):955-959. doi: 10.1097/SLA.0000000000003251.

PMID:
30973385
17.

Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence.

Poodt IGM, Vugts G, Schipper RJ, Roumen RMH, Rutten HJT, Maaskant-Braat AJG, Voogd AC, Nieuwenhuijzen GAP; Sentinel Node and Recurrent Breast Cancer (SNARB) study group.

Br J Surg. 2019 Apr;106(5):574-585. doi: 10.1002/bjs.11097.

PMID:
30908615
18.

Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.

Ramphal W, Boeding JRE, van Iwaarden M, Schreinemakers JMJ, Rutten HJT, Crolla RMPH, Gobardhan PD.

Int J Biol Markers. 2019 Mar;34(1):60-68. doi: 10.1177/1724600818820679. Epub 2019 Mar 11.

PMID:
30852955
19.

The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.

Arkenbosch JHC, van Erning FN, Rutten HJ, Zimmerman D, de Wilt JHW, Beijer S.

Eur J Surg Oncol. 2019 Feb;45(2):160-166. doi: 10.1016/j.ejso.2018.09.012. Epub 2018 Oct 16.

PMID:
30712552
20.

Oncologic outcome and recurrence rate following anastomotic leakage after curative resection for colorectal cancer.

Ramphal W, Boeding JRE, Gobardhan PD, Rutten HJT, de Winter LJMB, Crolla RMPH, Schreinemakers JMJ.

Surg Oncol. 2018 Dec;27(4):730-736. doi: 10.1016/j.suronc.2018.10.003. Epub 2018 Oct 10.

PMID:
30449500
21.

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Beets GL, Rutten HJT, Kusters M; Lateral Node Study Consortium.

J Clin Oncol. 2019 Jan 1;37(1):33-43. doi: 10.1200/JCO.18.00032. Epub 2018 Nov 7.

22.

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer.

Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Fürst A, Papamichael D, Desai AM, Cascinu S, Gèrard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, De Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA.

Eur J Surg Oncol. 2018 Nov;44(11):1685-1702. doi: 10.1016/j.ejso.2018.08.003. Epub 2018 Aug 15. Review.

PMID:
30150158
23.

Optimal management of localized rectal cancer in older patients.

Bujko K, Glynne-Jones R, Papamichael D, Rutten HJT.

J Geriatr Oncol. 2018 Nov;9(6):696-704. doi: 10.1016/j.jgo.2018.08.001. Epub 2018 Aug 24. Review.

PMID:
30150020
24.

Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer.

Schaap DP, Ogura A, Nederend J, Maas M, Cnossen JS, Creemers GJ, van Lijnschoten I, Nieuwenhuijzen GAP, Rutten HJT, Kusters M.

Br J Surg. 2018 Dec;105(13):1844-1852. doi: 10.1002/bjs.10949. Epub 2018 Aug 6.

PMID:
30079958
25.

Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.

Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E.

Br J Cancer. 2018 Aug;119(4):517-522. doi: 10.1038/s41416-018-0215-6. Epub 2018 Jul 30.

26.

Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O'Brien KM, Ortiz H, Janciauskiene R, Dekkers OM, Rutten HJT, Liefers GJ, Lemmens VEPP, van de Velde CJH.

Eur J Surg Oncol. 2018 Sep;44(9):1338-1343. doi: 10.1016/j.ejso.2018.05.025. Epub 2018 May 26.

PMID:
29960770
27.

Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?

Balyasnikova S, Vuong T, Wale A, Chong I, Rutten H, Brown G.

Colorectal Dis. 2018 May;20 Suppl 1:88-91. doi: 10.1111/codi.14086. Review.

PMID:
29878674
28.

Session 3: Beyond the boundaries of Total Mesorectal Excision - where surgeons fear to tread.

Patel A, Holm T, Wale A, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G.

Colorectal Dis. 2018 May;20 Suppl 1:61-64. doi: 10.1111/codi.14082. Review.

PMID:
29878672
29.

Session 3: Intra-operative radiotherapy - creating new surgical boundaries.

Patel A, Chang G, Wale A, Chong I, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G.

Colorectal Dis. 2018 May;20 Suppl 1:65-75. doi: 10.1111/codi.14083. Review.

PMID:
29878668
30.

The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery.

Smeets BJJ, Brinkman DJ, Horsten ECJ, Langius JAE, Rutten HJT, de Jonge WJ, Luyer MDP.

Nutr Cancer. 2018 Apr;70(3):460-466. doi: 10.1080/01635581.2018.1445763. Epub 2018 Mar 14.

PMID:
29537903
31.

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases.

Simkens GA, Rovers KP, van Oudheusden TR, Nienhuijs SW, Rutten HJ, de Hingh IH.

Medicine (Baltimore). 2018 Mar;97(10):e0042. doi: 10.1097/MD.0000000000010042.

32.

Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS II): a multicentre, double-blind, randomised controlled trial.

Peters EG, Smeets BJJ, Nors J, Back CM, Funder JA, Sommer T, Laurberg S, Løve US, Leclercq WKG, Slooter GD, de Vries Reilingh TS, Wegdam JA, Nieuwenhuijzen GAP, Hiligsmann M, Buise MP, Buurman WA, de Jonge WJ, Rutten HJT, Luyer MDP.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):242-251. doi: 10.1016/S2468-1253(18)30031-1. Epub 2018 Feb 14.

PMID:
29426699
33.

Health-related quality of life and cost-effectiveness analysis of gum chewing in patients undergoing colorectal surgery: results of a randomized controlled trial.

Pattamatta M, Smeets BJJ, Evers SMAA, Rutten HJT, Luyer MDP, Hiligsmann M.

Acta Chir Belg. 2018 Oct;118(5):299-306. doi: 10.1080/00015458.2018.1432742. Epub 2018 Jan 30.

PMID:
29378476
34.

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30.

PMID:
29361435
35.

Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.

Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M.

Chin J Cancer Res. 2017 Dec;29(6):521-532. doi: 10.21147/j.issn.1000-9604.2017.06.06.

36.

Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.

van Zoggel DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, Cnossen JS, Creemers GJ, van Lijnschoten G, Rutten HJT.

Br J Surg. 2018 Mar;105(4):447-452. doi: 10.1002/bjs.10694. Epub 2017 Nov 23.

PMID:
29168556
37.

Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.

Bos ACRK, Matthijsen RA, van Erning FN, van Oijen MGH, Rutten HJT, Lemmens VEPP.

Ann Surg Oncol. 2018 Feb;25(2):414-421. doi: 10.1245/s10434-017-6255-y. Epub 2017 Nov 20.

PMID:
29159744
38.

Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome.

van den Heijkant F, Vermeer TA, Vrijhof EJEJ, Nieuwenhuijzen GAP, Koldewijn EL, Rutten HJT.

Eur J Surg Oncol. 2017 Oct;43(10):1869-1875. doi: 10.1016/j.ejso.2017.05.018. Epub 2017 May 26.

PMID:
28732671
39.

Effect of Early vs Late Start of Oral Intake on Anastomotic Leakage Following Elective Lower Intestinal Surgery: A Systematic Review.

Smeets BJJ, Peters EG, Horsten ECJ, Weijs TJ, Rutten HJT, Buurman WA, de Jonge WJ, Luyer MDP.

Nutr Clin Pract. 2018 Dec;33(6):803-812. doi: 10.1177/0884533617711128. Epub 2017 Dec 14.

PMID:
28628353
40.

Congenital cytomegalovirus infection in Central Germany: an underestimated risk.

Rütten H, Rissmann A, Brett B, Costa SD, Doßow B, Färber J, Fest S, Fritzsch C, Lux A, Päge I, Spillner C, Redlich A.

Arch Gynecol Obstet. 2017 Aug;296(2):231-240. doi: 10.1007/s00404-017-4435-4. Epub 2017 Jun 17.

PMID:
28624987
41.

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.

Bisschop C, van Dijk TH, Beukema JC, Jansen RLH, Gelderblom H, de Jong KP, Rutten HJT, van de Velde CJH, Wiggers T, Havenga K, Hospers GAP.

Ann Surg Oncol. 2017 Sep;24(9):2632-2638. doi: 10.1245/s10434-017-5897-0. Epub 2017 May 30.

42.

Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study.

Gurney-Champion OJ, Versteijne E, van der Horst A, Lens E, Rütten H, Heerkens HD, Paardekooper GMRM, Berbee M, Rasch CRN, Stoker J, Engelbrecht MRW, van Herk M, Nederveen AJ, Klaassen R, van Laarhoven HWM, van Tienhoven G, Bel A.

Acta Oncol. 2017 Jul;56(7):923-930. doi: 10.1080/0284186X.2017.1304654. Epub 2017 Apr 4.

PMID:
28375667
43.

Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven.

Holman FA, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, van den Berg HA, Nelson H, Rutten HJ.

J Gastrointest Oncol. 2016 Dec;7(6):903-916. doi: 10.21037/jgo.2016.07.01.

44.

Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.

Simkens GA, van Oudheusden TR, Nieboer D, Steyerberg EW, Rutten HJ, Luyer MD, Nienhuijs SW, de Hingh IH.

Ann Surg Oncol. 2016 Dec;23(13):4214-4221. Epub 2016 Mar 30.

PMID:
27027308
45.

Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study).

Musters GD, Klaver CEL, Bosker RJI, Burger JWA, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Leijtens JWA, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Tanis PJ.

Ann Surg. 2017 Jun;265(6):1074-1081. doi: 10.1097/SLA.0000000000002020.

PMID:
27768621
46.

Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.

Simkens GA, Verwaal VJ, Lemmens VE, Rutten HJ, de Hingh IH.

Medicine (Baltimore). 2016 Oct;95(41):e5111.

47.

Corrigendum to "2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer" [Eur J Cancer 63 (August 2016) 11-24].

Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G, Bujko K, Cunningham C, Evrard S, Folprecht G, Gerard JP, Habr-Gama A, Haustermans K, Holm T, Kuhlmann KF, Lordick F, Mentha G, Moehler M, Nagtegaal ID, Pigazzi A, Pucciarelli S, Roth A, Rutten H, Schmoll HJ, Sorbye H, Van Cutsem E, Weitz J, Otto F.

Eur J Cancer. 2016 Nov;68:208-209. doi: 10.1016/j.ejca.2016.08.017. Epub 2016 Oct 4. No abstract available.

48.

Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.

Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, van den Berg H, Nelson H, Rutten HJ.

Eur J Surg Oncol. 2017 Jan;43(1):107-117. doi: 10.1016/j.ejso.2016.08.015. Epub 2016 Sep 9.

PMID:
27659000
49.

No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.

Bos AC, van Erning FN, Elferink MA, Rutten HJ, van Oijen MG, de Wilt JH, Lemmens VE.

Dis Colon Rectum. 2016 Oct;59(10):943-52. doi: 10.1097/DCR.0000000000000660.

PMID:
27602925
50.

Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.

Beek MA, Gobardhan PD, Schoenmaeckers EJ, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ.

Breast Cancer Res Treat. 2016 Aug;158(3):421-32. doi: 10.1007/s10549-016-3920-y. Epub 2016 Jul 21. Review.

PMID:
27444925

Supplemental Content

Loading ...
Support Center